Neurocrine Biosciences (NBIX) had its best year since May 23, 1996 in 1999, returning 253.6%.

ASSET	YEAR	% RETURN
Neurocrine Biosciences (NBIX)	1996	-20%
Neurocrine Biosciences (NBIX)	1997	-20.25%
Neurocrine Biosciences (NBIX)	1998	-14.06%
Neurocrine Biosciences (NBIX)	1999	253.57%
Neurocrine Biosciences (NBIX)	2000	27.4%
Neurocrine Biosciences (NBIX)	2001	53.24%
Neurocrine Biosciences (NBIX)	2002	-11.24%
Neurocrine Biosciences (NBIX)	2003	19.66%
Neurocrine Biosciences (NBIX)	2004	-9.58%
Neurocrine Biosciences (NBIX)	2005	27.14%
Neurocrine Biosciences (NBIX)	2006	-83.55%
Neurocrine Biosciences (NBIX)	2007	-56.43%
Neurocrine Biosciences (NBIX)	2008	-28.57%
Neurocrine Biosciences (NBIX)	2009	-15.26%
Neurocrine Biosciences (NBIX)	2010	175.81%
Neurocrine Biosciences (NBIX)	2011	10.1%
Neurocrine Biosciences (NBIX)	2012	-14.42%
Neurocrine Biosciences (NBIX)	2013	21.61%
Neurocrine Biosciences (NBIX)	2014	140.99%
Neurocrine Biosciences (NBIX)	2015	150.42%
Neurocrine Biosciences (NBIX)	2016	-30.02%
Neurocrine Biosciences (NBIX)	2017	100.03%
Neurocrine Biosciences (NBIX)	2018	-7.89%
Neurocrine Biosciences (NBIX)	2019	53.03%
Neurocrine Biosciences (NBIX)	2020	-11.25%